Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pancreatic Adenocarcinoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 HER2-positive Breast Cancer 1 Cystic Fibrosis 1 Breast Neoplasms 1

Interventions

Dexamethasone 363 Bortezomib 232 Lenalidomide 202 Cyclophosphamide 174 Melphalan 154 Calcium Dobesilate 107 Peripheral Blood Stem Cell Transplantation 92 fludarabine phosphate 84 Thalidomide 81 Filgrastim 71 carfilzomib 68 pomalidomide 66 Granulocyte Colony-Stimulating Factor 60 Mycophenolic Acid 59 Busulfan 57 daratumumab 55 Whole-Body Irradiation 54 Tacrolimus 51 ixazomib 50 Prednisone 50 Cyclosporine 49 fludarabine 46 Antilymphocyte Serum 35 Etoposide 30 dexamethasone acetate 29 Methotrexate 29 plerixafor 27 Radiotherapy 26 Doxorubicin 26 dexamethasone 21-phosphate 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Multiple Myeloma × Electronic Health Records × Clear all

NCT03638232 2018-08-20

Myeloma Treatment in Real Life

University Hospital, Toulouse

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡